姓名:許雅玲 (Ya-Ling Hsu) 教授 | |
分機:2136 ext.26 | |
EMail:yainghsu@kmu.edu.tw | |
現任:高雄醫學大學醫學研究所教授 & 研究資源整合發展中心 主任 | |
學歷:高雄醫學大學天然藥物研究所-藥學博士 | |
專長:1.分子細胞生物學 2.腫瘤微環境 |
近期著作: | ||||||||
1.Hsu YL, Hung JY, Chang WA, Jian SF, Lin YS, Pan YC, Wu CY, Kuo PL*. Hypoxic lung cancer-derived extracellular vesicle miR-103a increases the oncogenic effects of tumor associated macrophages by targeting PTEN. Molecular Therapy 2018 Feb 7;26(2):582- 92. (SCI; IF=7.008) |
||||||||
2.Hsu YL, Hung JY, Chang WA, Lin YS, Pan YC, Tsai PH, Wu CY, Kuo PL*. Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene 2017 Aug 24;36(34):4929-42. (SCI; IF=6.854) |
||||||||
3.Hsu YL, Hung JY, Chou SH, Huang MS, Tsai MJ, Lin YS, Chiang SY, Ho YW, Wu CY, Kuo PL*. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression. Oncogene 2015 Jul 30;34(31):4056-68. (SCI; IF=6.854) |
||||||||
4.Kuo PL, Huang MS, Hung JY, Chou SH, Chiang SY, Huang YF, Yang CJ, Tsai MJ, Chang WA, Hsu YL*. Synergistic effect of lung tumor-associated dendritic cell-derived HB-EGF and CXCL5 on cancer progression. International Journal of Cancer 2014 Jul 1;135(1):96-108. (SCI; IF=7.360) |
||||||||
5.Hsieh CJ, Kuo PL, Hsu YC, Huang YF, Tsai EM*, Hsu YL*. Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS/p38 MAPK pathway and epigenetic regulation. Free Radical Biology & Medicine 2014 Feb;67:159-70. (SCI; IF=6.020) |
||||||||
6.Hsu YL*, Hou MF, Kuo PL, Huang YF, and Tsai EM. Breast tumor-associated osteoblast- derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene 2013 Sep 12;32(37):4436-47. (SCI; IF=6.854) |
||||||||